{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:31:19Z","timestamp":1793392279470,"version":"4.5.0"},"reference-count":140,"publisher":"The Pediatric Pharmacy Association","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"abstract":"<jats:p>Cancer remains the leading cause of death from disease in children. Historically, in contrast to their adult counterparts, the causes of pediatric malignancies have remained largely unknown, with most pediatric cancers displaying low mutational burdens. Research related to molecular genetics in pediatric cancers is advancing our understanding of potential drivers of tumorigenesis and opening new opportunities for targeted therapies. One such area is fusion oncoproteins, which are a product of chromosomal rearrangements resulting in the fusion of different genes. They have been identified as oncogenic drivers in several sarcomas and leukemias. Continued advancement in the understanding of the biology of fusion oncoproteins will contribute to the discovery and development of new therapies for childhood cancers. Here we review the current scientific knowledge on fusion oncoproteins, focusing on pediatric sarcomas and hematologic cancers, and highlight the challenges and current efforts in developing drugs to target fusion oncoproteins.<\/jats:p>","DOI":"10.5863\/1551-6776-26.6.541","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T20:47:11Z","timestamp":1629146831000},"page":"541-555","source":"Crossref","is-referenced-by-count":4,"title":["Fusion Oncoproteins in Childhood Cancers: Potential Role in Targeted Therapy"],"prefix":"10.5863","volume":"26","author":[{"given":"Sara D. A.","family":"Angione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemayehu Y.","family":"Akalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gartrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elimika Pfuma","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert J.","family":"Burckart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory H.","family":"Reaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton F.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","reference":[{"key":"i1551-6776-26-6-541-b1","article-title":"Cancer in children and adolescents","unstructured":"NIH.\n          \n          Cancer in children and adolescents.\n\t\t\t\t\tUpdated October 8, 2018. Accessed September 3, 2020. https:\/\/www.cancer.gov\/types\/childhood-cancers\/child-adolescent-cancers-fact-sheet"},{"key":"i1551-6776-26-6-541-b2","article-title":"Childhood cancer: statistics","unstructured":"ASCO.\n          \n          Childhood cancer: statistics.\n\t\t\t\t\tUpdated January 2020. Accessed September 3, 2020. https:\/\/www.cancer.net\/cancer-types\/childhood-cancer\/statistics"},{"key":"i1551-6776-26-6-541-b3","article-title":"Childhood cancers research","unstructured":"NCI.\n          \n          Childhood cancers research.\n\t\t\t\t\tUpdated June 5, 2020. Accessed September 10, 2020. https:\/\/www.cancer.gov\/research\/areas\/childhood"},{"issue":"6","key":"i1551-6776-26-6-541-b4","series-title":"J Mol Diagn","first-page":"765","article-title":"OncoKids: a comprehensive next-generation sequencing panel for pediatric malignancies","volume":"20","year":"2018","unstructured":"Hiemenz\n              MC,\n            \n            \n              Ostrow\n              DG,\n            \n            \n              Busse\n              TM,\n            \n          \n          .\n\t\t\t\t\tOncoKids: a comprehensive next-generation sequencing panel for pediatric malignancies.\n\t\t\t\t\tJ Mol Diagn.\n\t\t\t\t\t2018;\n\t\t\t\t\t20(\n\t\t\t\t\t6):\n\t\t\t\t\t765\u2013\n\t\t\t\t\t776."},{"issue":"7696","key":"i1551-6776-26-6-541-b5","series-title":"Nature","first-page":"321","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","year":"2018","unstructured":"Grobner\n              SN,\n            \n            \n              Worst\n              BC,\n            \n            \n              Weischenfeldt\n              J,\n            \n          \n          .\n\t\t\t\t\tThe landscape of genomic alterations across childhood cancers.\n\t\t\t\t\tNature.\n\t\t\t\t\t2018;\n\t\t\t\t\t555(\n\t\t\t\t\t7696):\n\t\t\t\t\t321\u2013\n\t\t\t\t\t327."},{"issue":"1","key":"i1551-6776-26-6-541-b6","series-title":"Mol Ther","first-page":"200","article-title":"Discovery of new fusion transcripts in a cohort of pediatric solid cancers at relapse and relevance for personalized medicine","volume":"27","year":"2019","unstructured":"Dupain\n              C,\n            \n            \n              Harttrampf\n              AC,\n            \n            \n              Boursin\n              Y,\n            \n          \n          .\n\t\t\t\t\tDiscovery of new fusion transcripts in a cohort of pediatric solid cancers at relapse and relevance for personalized medicine.\n\t\t\t\t\tMol Ther.\n\t\t\t\t\t2019;\n\t\t\t\t\t27(\n\t\t\t\t\t1):\n\t\t\t\t\t200\u2013\n\t\t\t\t\t218."},{"key":"i1551-6776-26-6-541-b7","series-title":"Cancer Lett","first-page":"3","article-title":"Screening and identification of molecular targets for cancer therapy","volume":"387","year":"2017","unstructured":"Abdelmoez\n              A,\n            \n            \n              Coraca-Huber\n              DC,\n            \n            \n              Thurner\n              GC,\n            \n          \n          .\n\t\t\t\t\tScreening and identification of molecular targets for cancer therapy.\n\t\t\t\t\tCancer Lett.\n\t\t\t\t\t2017;\n\t\t\t\t\t387:\n\t\t\t\t\t3\u2013\n\t\t\t\t\t9."},{"key":"i1551-6776-26-6-541-b8","article-title":"Targeted cancer therapies","unstructured":"NIH.\n          \n          Targeted cancer therapies.\n\t\t\t\t\tUpdated July 17, 2020. Accessed September 3, 2020. https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/targeted-therapies\/targeted-therapies-fact-sheet"},{"issue":"7696","key":"i1551-6776-26-6-541-b9","series-title":"Nature","first-page":"371","article-title":"Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours","volume":"555","year":"2018","unstructured":"Ma\n              X,\n            \n            \n              Liu\n              Y,\n            \n            \n              Liu\n              Y,\n            \n          \n          .\n\t\t\t\t\tPan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.\n\t\t\t\t\tNature.\n\t\t\t\t\t2018;\n\t\t\t\t\t555(\n\t\t\t\t\t7696):\n\t\t\t\t\t371\u2013\n\t\t\t\t\t376."},{"key":"i1551-6776-26-6-541-b10","article-title":"Childhood cancers research","unstructured":"NCI.\n          \n          Childhood cancers research.\n\t\t\t\t\tUpdated June 5, 2019. Accessed September 3, 2020. https:\/\/www.cancer.gov\/research\/areas\/childhood"},{"key":"i1551-6776-26-6-541-b11","article-title":"Fusion gene","unstructured":"NCI.\n          \n          Fusion gene.\n\t\t\t\t\tAccessed September 9, 2020. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms"},{"issue":"12","key":"i1551-6776-26-6-541-b12","series-title":"Blood","first-page":"1241","article-title":"Targeted therapy for fusion-driven high-risk acute leukemia","volume":"132","year":"2018","unstructured":"Pikman\n              Y,\n            \n            \n              Stegmaier\n              K.\n            \n          \n          Targeted therapy for fusion-driven high-risk acute leukemia.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2018;\n\t\t\t\t\t132(\n\t\t\t\t\t12):\n\t\t\t\t\t1241\u2013\n\t\t\t\t\t1247."},{"key":"i1551-6776-26-6-541-b13","series-title":"Mol Ther Nucleic Acids","first-page":"315","article-title":"Relevance of fusion genes in pediatric cancers: toward precision medicine","volume":"6","year":"2017","unstructured":"Dupain\n              C,\n            \n            \n              Harttrampf\n              AC,\n            \n            \n              Urbinati\n              G,\n            \n          \n          .\n\t\t\t\t\tRelevance of fusion genes in pediatric cancers: toward precision medicine.\n\t\t\t\t\tMol Ther Nucleic Acids.\n\t\t\t\t\t2017;\n\t\t\t\t\t6:\n\t\t\t\t\t315\u2013\n\t\t\t\t\t326."},{"issue":"6405","key":"i1551-6776-26-6-541-b14","series-title":"Science","article-title":"Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors","volume":"361","year":"2018","unstructured":"Anderson\n              ND,\n            \n            \n              de Borja\n              R,\n            \n            \n              Young\n              MD,\n            \n          \n          .\n\t\t\t\t\tRearrangement bursts generate canonical gene fusions in bone and soft tissue tumors.\n\t\t\t\t\tScience.\n\t\t\t\t\t2018;\n\t\t\t\t\t361(\n\t\t\t\t\t6405)\n\t\t\t\t\teaam8419. doi: 10.1126\/science.aam8419"},{"issue":"1","key":"i1551-6776-26-6-541-b15","series-title":"J Hematol Oncol","first-page":"148","article-title":"Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles","volume":"10","year":"2017","unstructured":"Marincevic-Zuniga\n              Y,\n            \n            \n              Dahlberg\n              J,\n            \n            \n              Nilsson\n              S,\n            \n          \n          .\n\t\t\t\t\tTranscriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles.\n\t\t\t\t\tJ Hematol Oncol.\n\t\t\t\t\t2017;\n\t\t\t\t\t10(\n\t\t\t\t\t1):\n\t\t\t\t\t148.\n\t\t\t\t\tdoi: 10.1186\/s13045-017-0515-y"},{"issue":"4","key":"i1551-6776-26-6-541-b16","series-title":"Genome Res","first-page":"505","article-title":"RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology","volume":"21","year":"2011","unstructured":"Lawson\n              AR,\n            \n            \n              Hindley\n              GF,\n            \n            \n              Forshew\n              T,\n            \n          \n          .\n\t\t\t\t\tRAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology.\n\t\t\t\t\tGenome Res.\n\t\t\t\t\t2011;\n\t\t\t\t\t21(\n\t\t\t\t\t4):\n\t\t\t\t\t505\u2013\n\t\t\t\t\t514."},{"issue":"4","key":"i1551-6776-26-6-541-b17","series-title":"Growth Horm IGF Res","first-page":"130","article-title":"Investigation of IGF2, Hedgehog and fusion gene expression profiles in pediatric sarcomas","volume":"24","year":"2014","unstructured":"de Souza\n              RR,\n            \n            \n              Oliveira\n              ID,\n            \n            \n              del Giudice Paniago\n              M,\n            \n          \n          .\n\t\t\t\t\tInvestigation of IGF2, Hedgehog and fusion gene expression profiles in pediatric sarcomas.\n\t\t\t\t\tGrowth Horm IGF Res.\n\t\t\t\t\t2014;\n\t\t\t\t\t24(\n\t\t\t\t\t4):\n\t\t\t\t\t130\u2013\n\t\t\t\t\t136."},{"issue":"5","key":"i1551-6776-26-6-541-b18","series-title":"Cancer Genet","first-page":"182","article-title":"Current state of pediatric sarcoma biology and opportunities for future discovery: a report from the sarcoma translational research workshop","volume":"209","year":"2016","unstructured":"Hingorani\n              P,\n            \n            \n              Janeway\n              K,\n            \n            \n              Crompton\n              BD,\n            \n          \n          .\n\t\t\t\t\tCurrent state of pediatric sarcoma biology and opportunities for future discovery: a report from the sarcoma translational research workshop.\n\t\t\t\t\tCancer Genet.\n\t\t\t\t\t2016;\n\t\t\t\t\t209(\n\t\t\t\t\t5):\n\t\t\t\t\t182\u2013\n\t\t\t\t\t194."},{"issue":"3","key":"i1551-6776-26-6-541-b19","series-title":"Cancer Chemother Pharmacol","first-page":"645","article-title":"A phase I\/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWSFLI1 fusion transcript","volume":"80","year":"2017","unstructured":"Grohar\n              PJ,\n            \n            \n              Glod\n              J,\n            \n            \n              Peer\n              CJ,\n            \n          \n          .\n\t\t\t\t\tA phase I\/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWSFLI1 fusion transcript.\n\t\t\t\t\tCancer Chemother Pharmacol.\n\t\t\t\t\t2017;\n\t\t\t\t\t80(\n\t\t\t\t\t3):\n\t\t\t\t\t645\u2013\n\t\t\t\t\t652."},{"issue":"3","key":"i1551-6776-26-6-541-b20","series-title":"Cell Rep","first-page":"598","article-title":"Functional genomic screening reveals splicing of the EWS-FLI1 fusion transcript as a vulnerability in Ewing sarcoma","volume":"14","year":"2016","unstructured":"Grohar\n              PJ,\n            \n            \n              Kim\n              S,\n            \n            \n              Rangel Rivera\n              GO,\n            \n          \n          .\n\t\t\t\t\tFunctional genomic screening reveals splicing of the EWS-FLI1 fusion transcript as a vulnerability in Ewing sarcoma.\n\t\t\t\t\tCell Rep.\n\t\t\t\t\t2016;\n\t\t\t\t\t14(\n\t\t\t\t\t3):\n\t\t\t\t\t598\u2013\n\t\t\t\t\t610."},{"issue":"1","key":"i1551-6776-26-6-541-b21","series-title":"Nat Commun","first-page":"1388","article-title":"Diagnosis of fusion genes using targeted RNA sequencing","volume":"10","year":"2019","unstructured":"Heyer\n              EE,\n            \n            \n              Deveson\n              IW,\n            \n            \n              Wooi\n              D,\n            \n          \n          .\n\t\t\t\t\tDiagnosis of fusion genes using targeted RNA sequencing.\n\t\t\t\t\tNat Commun.\n\t\t\t\t\t2019;\n\t\t\t\t\t10(\n\t\t\t\t\t1):\n\t\t\t\t\t1388.\n\t\t\t\t\tdoi:XXX"},{"issue":"40","key":"i1551-6776-26-6-541-b22","series-title":"Onco-gene","first-page":"5736","article-title":"Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma","volume":"20","unstructured":"Barr\n              FG.\n            \n          \n          Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.\n\t\t\t\t\tOnco-gene.\n\t\t\t\t\t20(\n\t\t\t\t\t40):\n\t\t\t\t\t5736\u2013\n\t\t\t\t\t5746."},{"issue":"1","key":"i1551-6776-26-6-541-b23","series-title":"Am J Pathol","first-page":"179","article-title":"Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents","volume":"159","year":"2001","unstructured":"Argani\n              P,\n            \n            \n              Antonescu\n              CR,\n            \n            \n              Illei\n              PB,\n            \n          \n          .\n\t\t\t\t\tPrimary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.\n\t\t\t\t\tAm J Pathol.\n\t\t\t\t\t2001;\n\t\t\t\t\t159(\n\t\t\t\t\t1):\n\t\t\t\t\t179\u2013\n\t\t\t\t\t192."},{"issue":"1","key":"i1551-6776-26-6-541-b24","series-title":"Oncogene","first-page":"48","article-title":"The der(17)t(X;17) (p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25","volume":"20","year":"2001","unstructured":"Ladanyi\n              M,\n            \n            \n              Lui\n              MY,\n            \n            \n              Antonescu\n              CR,\n            \n          \n          .\n\t\t\t\t\tThe der(17)t(X;17) (p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.\n\t\t\t\t\tOncogene.\n\t\t\t\t\t2001;\n\t\t\t\t\t20(\n\t\t\t\t\t1):\n\t\t\t\t\t48\u2013\n\t\t\t\t\t57."},{"issue":"21","key":"i1551-6776-26-6-541-b25","series-title":"Oncogene","first-page":"3419","article-title":"Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes","volume":"24","year":"2005","unstructured":"Oliveira\n              AM,\n            \n            \n              Perez-Atayde\n              AR,\n            \n            \n              Dal Cin\n              P,\n            \n          \n          .\n\t\t\t\t\tAneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes.\n\t\t\t\t\tOncogene.\n\t\t\t\t\t2005;\n\t\t\t\t\t24(\n\t\t\t\t\t21):\n\t\t\t\t\t3419\u2013\n\t\t\t\t\t3426."},{"key":"i1551-6776-26-6-541-b26","series-title":"Cancer Genet","first-page":"12","article-title":"Primary aneurysmal bone cyst with a novel SPARC-USP6 translocation identified by next-generation sequencing","volume":"228\u2013229","year":"2018","unstructured":"Sekoranja\n              D,\n            \n            \n              Bostjancic\n              E,\n            \n            \n              Salapura\n              V,\n            \n          \n          .\n\t\t\t\t\tPrimary aneurysmal bone cyst with a novel SPARC-USP6 translocation identified by next-generation sequencing.\n\t\t\t\t\tCancer Genet.\n\t\t\t\t\t2018;\n\t\t\t\t\t228\u2013229:\n\t\t\t\t\t12\u2013\n\t\t\t\t\t16."},{"issue":"5","key":"i1551-6776-26-6-541-b27","series-title":"Am J Pathol","first-page":"1773","article-title":"USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts","volume":"165","year":"2004","unstructured":"Oliveira\n              AM,\n            \n            \n              Perez-Atayde\n              AR,\n            \n            \n              Inwards\n              CY,\n            \n          \n          .\n\t\t\t\t\tUSP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts.\n\t\t\t\t\tAm J Pathol.\n\t\t\t\t\t2004;\n\t\t\t\t\t165(\n\t\t\t\t\t5):\n\t\t\t\t\t1773\u2013\n\t\t\t\t\t1780."},{"issue":"18","key":"i1551-6776-26-6-541-b28","series-title":"Clin Cancer Res","first-page":"5356","article-title":"EWS-CREB1: a recurrent variant fusion in clear cell sarcoma\u2014association with gastrointestinal location and absence of melanocytic differentiation","volume":"12","year":"2006","unstructured":"Antonescu\n              CR,\n            \n            \n              Nafa\n              K,\n            \n            \n              Segal\n              NH,\n            \n          \n          .\n\t\t\t\t\tEWS-CREB1: a recurrent variant fusion in clear cell sarcoma\u2014association with gastrointestinal location and absence of melanocytic differentiation.\n\t\t\t\t\tClin Cancer Res.\n\t\t\t\t\t2006;\n\t\t\t\t\t12(\n\t\t\t\t\t18):\n\t\t\t\t\t5356\u2013\n\t\t\t\t\t5362."},{"issue":"2","key":"i1551-6776-26-6-541-b29","series-title":"Cancer Genet Cytogenet","first-page":"109","article-title":"Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11","volume":"121","year":"2000","unstructured":"Waters\n              BL,\n            \n            \n              Panagopoulos\n              I,\n            \n            \n              Allen\n              EF.\n            \n          \n          Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11.\n\t\t\t\t\tCancer Genet Cytogenet.\n\t\t\t\t\t2000;\n\t\t\t\t\t121(\n\t\t\t\t\t2):\n\t\t\t\t\t109\u2013\n\t\t\t\t\t116."},{"issue":"11","key":"i1551-6776-26-6-541-b30","series-title":"Cancer Genet","first-page":"387","article-title":"Multiple EWSR1-WT1 and WT1-EWSR1 copies in two cases of desmoplastic round cell tumor","volume":"206","year":"2013","unstructured":"La Starza\n              R,\n            \n            \n              Barba\n              G,\n            \n            \n              Nofrini\n              V,\n            \n          \n          .\n\t\t\t\t\tMultiple EWSR1-WT1 and WT1-EWSR1 copies in two cases of desmoplastic round cell tumor.\n\t\t\t\t\tCancer Genet.\n\t\t\t\t\t2013;\n\t\t\t\t\t206(\n\t\t\t\t\t11):\n\t\t\t\t\t387\u2013\n\t\t\t\t\t392."},{"issue":"3","key":"i1551-6776-26-6-541-b31","series-title":"Semin Cancer Biol","first-page":"197","article-title":"The EWS-WT1 gene fusion in desmoplastic small round cell tumor","volume":"15","year":"2005","unstructured":"Gerald\n              WL,\n            \n            \n              Haber\n              DA.\n            \n          \n          The EWS-WT1 gene fusion in desmoplastic small round cell tumor.\n\t\t\t\t\tSemin Cancer Biol.\n\t\t\t\t\t2005;\n\t\t\t\t\t15(\n\t\t\t\t\t3):\n\t\t\t\t\t197\u2013\n\t\t\t\t\t205."},{"key":"i1551-6776-26-6-541-b32","series-title":"Orphanet J Rare Dis","first-page":"15","article-title":"JAZF1\/SUZ12 gene fusion in endometrial stromal sarcomas","volume":"11","year":"2016","unstructured":"Hrzenjak\n              A.\n            \n          \n          JAZF1\/SUZ12 gene fusion in endometrial stromal sarcomas.\n\t\t\t\t\tOrphanet J Rare Dis.\n\t\t\t\t\t2016;\n\t\t\t\t\t11:\n\t\t\t\t\t15.\n\t\t\t\t\tdoi: 10.1186\/s13023-016-0400-8"},{"issue":"2","key":"i1551-6776-26-6-541-b33","series-title":"Cancer Genet Cytogenet","first-page":"74","article-title":"An endometrial stromal sarcoma cell line with the JAZF1\/PHF1 chimera","volume":"185","year":"2008","unstructured":"Panagopoulos\n              I,\n            \n            \n              Mertens\n              F,\n            \n            \n              Griffin\n              CA.\n            \n          \n          An endometrial stromal sarcoma cell line with the JAZF1\/PHF1 chimera.\n\t\t\t\t\tCancer Genet Cytogenet.\n\t\t\t\t\t2008;\n\t\t\t\t\t185(\n\t\t\t\t\t2):\n\t\t\t\t\t74\u2013\n\t\t\t\t\t77."},{"issue":"5","key":"i1551-6776-26-6-541-b34","series-title":"Am J Surg Pathol","first-page":"641","article-title":"The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor","volume":"36","year":"2012","unstructured":"Lee\n              CH,\n            \n            \n              Marino-Enriquez\n              A,\n            \n            \n              Ou\n              W,\n            \n          \n          .\n\t\t\t\t\tThe clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2012;\n\t\t\t\t\t36(\n\t\t\t\t\t5):\n\t\t\t\t\t641\u2013\n\t\t\t\t\t653."},{"issue":"1","key":"i1551-6776-26-6-541-b35","series-title":"Cancer Lett","first-page":"75","article-title":"MEAF6\/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma","volume":"347","year":"2014","unstructured":"Micci\n              F,\n            \n            \n              Gorunova\n              L,\n            \n            \n              Gatius\n              S,\n            \n          \n          .\n\t\t\t\t\tMEAF6\/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma.\n\t\t\t\t\tCancer Lett.\n\t\t\t\t\t2014;\n\t\t\t\t\t347(\n\t\t\t\t\t1):\n\t\t\t\t\t75\u2013\n\t\t\t\t\t78."},{"issue":"5","key":"i1551-6776-26-6-541-b36","series-title":"Am J Surg Pathol","first-page":"684","article-title":"Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma","volume":"25","year":"2001","unstructured":"Mendlick\n              MR,\n            \n            \n              Nelson\n              M,\n            \n            \n              Pickering\n              D,\n            \n          \n          .\n\t\t\t\t\tTranslocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2001;\n\t\t\t\t\t25(\n\t\t\t\t\t5):\n\t\t\t\t\t684\u2013\n\t\t\t\t\t687."},{"issue":"98","key":"i1551-6776-26-6-541-b37","series-title":"Sci Transl Med","first-page":"98ra82","article-title":"Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma","volume":"3","year":"2011","unstructured":"Tanas\n              MR,\n            \n            \n              Sboner\n              A,\n            \n            \n              Oliveira\n              AM,\n            \n          \n          .\n\t\t\t\t\tIdentification of a disease-defining gene fusion in epithelioid hemangioendothelioma.\n\t\t\t\t\tSci Transl Med.\n\t\t\t\t\t2011;\n\t\t\t\t\t3(\n\t\t\t\t\t98):\n\t\t\t\t\t98ra82.\n\t\t\t\t\tdoi: 10.1126\/scitranslmed.3002409"},{"issue":"499","key":"i1551-6776-26-6-541-b38","series-title":"Sci Signal","article-title":"Inhibition of the oncogenic fusion protein EWS-FLI1 causes G2-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcoma","volume":"10","year":"2017","unstructured":"Zollner\n              SK,\n            \n            \n              Selvanathan\n              SP,\n            \n            \n              Graham\n              GT,\n            \n          \n          .\n\t\t\t\t\tInhibition of the oncogenic fusion protein EWS-FLI1 causes G2-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcoma.\n\t\t\t\t\tSci Signal.\n\t\t\t\t\t2017;\n\t\t\t\t\t10(\n\t\t\t\t\t499).\n\t\t\t\t\tdoi: 10.1126\/scisignal.aam8429"},{"issue":"7","key":"i1551-6776-26-6-541-b39","series-title":"Cancer Genet","first-page":"351","article-title":"Promiscuous partnerships in Ewing's sarcoma","volume":"204","year":"2011","unstructured":"Sankar\n              S,\n            \n            \n              Lessnick\n              SL.\n            \n          \n          Promiscuous partnerships in Ewing's sarcoma.\n\t\t\t\t\tCancer Genet.\n\t\t\t\t\t2011;\n\t\t\t\t\t204(\n\t\t\t\t\t7):\n\t\t\t\t\t351\u2013\n\t\t\t\t\t365."},{"issue":"6391","key":"i1551-6776-26-6-541-b40","series-title":"Nature","first-page":"162","article-title":"Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours","volume":"359","year":"1992","unstructured":"Delattre\n              O,\n            \n            \n              Zucman\n              J,\n            \n            \n              Plougastel\n              B,\n            \n          \n          .\n\t\t\t\t\tGene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours.\n\t\t\t\t\tNature.\n\t\t\t\t\t1992;\n\t\t\t\t\t359(\n\t\t\t\t\t6391):\n\t\t\t\t\t162\u2013\n\t\t\t\t\t165."},{"issue":"3","key":"i1551-6776-26-6-541-b41","series-title":"Genes Chromosomes Cancer","first-page":"260","article-title":"Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans","volume":"47","year":"2008","unstructured":"Macarenco\n              RS,\n            \n            \n              Zamolyi\n              R,\n            \n            \n              Franco\n              MF,\n            \n          \n          .\n\t\t\t\t\tGenomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.\n\t\t\t\t\tGenes Chromosomes Cancer.\n\t\t\t\t\t2008;\n\t\t\t\t\t47(\n\t\t\t\t\t3):\n\t\t\t\t\t260\u2013\n\t\t\t\t\t265."},{"issue":"8","key":"i1551-6776-26-6-541-b42","series-title":"Pediatr Blood Cancer","first-page":"1468","article-title":"Infantile fibrosarcoma with NTRK3-ETV6 fusion successfully treated with the tropomyosin-related kinase inhibitor LOXO-101","volume":"63","year":"2016","unstructured":"Nagasubramanian\n              R,\n            \n            \n              Wei\n              J,\n            \n            \n              Gordon\n              P,\n            \n          \n          .\n\t\t\t\t\tInfantile fibrosarcoma with NTRK3-ETV6 fusion successfully treated with the tropomyosin-related kinase inhibitor LOXO-101.\n\t\t\t\t\tPediatr Blood Cancer.\n\t\t\t\t\t2016;\n\t\t\t\t\t63(\n\t\t\t\t\t8):\n\t\t\t\t\t1468\u2013\n\t\t\t\t\t1470."},{"issue":"8","key":"i1551-6776-26-6-541-b43","series-title":"Leuk Res","first-page":"945","article-title":"ETV6 fusion genes in hematological malignancies: a review","volume":"36","year":"2012","unstructured":"De Braekeleer\n              E,\n            \n            \n              Douet-Guilbert\n              N,\n            \n            \n              Morel\n              F,\n            \n          \n          .\n\t\t\t\t\tETV6 fusion genes in hematological malignancies: a review.\n\t\t\t\t\tLeuk Res.\n\t\t\t\t\t2012;\n\t\t\t\t\t36(\n\t\t\t\t\t8):\n\t\t\t\t\t945\u2013\n\t\t\t\t\t961."},{"issue":"2","key":"i1551-6776-26-6-541-b44","series-title":"Oncogene","first-page":"270","article-title":"The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ","volume":"28","year":"2009","unstructured":"Goransson\n              M,\n            \n            \n              Andersson\n              MK,\n            \n            \n              Forni\n              C,\n            \n          \n          .\n\t\t\t\t\tThe myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.\n\t\t\t\t\tOncogene.\n\t\t\t\t\t2009;\n\t\t\t\t\t28(\n\t\t\t\t\t2):\n\t\t\t\t\t270\u2013\n\t\t\t\t\t278."},{"issue":"2","key":"i1551-6776-26-6-541-b45","series-title":"Am J Surg Pathol","first-page":"224","article-title":"A molecular study of pediatric spindle and sclerosing rhabdomyosarcoma: identification of novel and recurrent VGLL2-related fusions in infantile cases","volume":"40","year":"2016","unstructured":"Alaggio\n              R,\n            \n            \n              Zhang\n              L,\n            \n            \n              Sung\n              YS,\n            \n          \n          .\n\t\t\t\t\tA molecular study of pediatric spindle and sclerosing rhabdomyosarcoma: identification of novel and recurrent VGLL2-related fusions in infantile cases.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2016;\n\t\t\t\t\t40(\n\t\t\t\t\t2):\n\t\t\t\t\t224\u2013\n\t\t\t\t\t235."},{"issue":"5","key":"i1551-6776-26-6-541-b46","series-title":"Genes Chromosomes Cancer","first-page":"510","article-title":"Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8) (p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes","volume":"51","year":"2012","unstructured":"Jin\n              Y,\n            \n            \n              Moller\n              E,\n            \n            \n              Nord\n              KH,\n            \n          \n          .\n\t\t\t\t\tFusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8) (p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes.\n\t\t\t\t\tGenes Chromosomes Cancer.\n\t\t\t\t\t2012;\n\t\t\t\t\t51(\n\t\t\t\t\t5):\n\t\t\t\t\t510\u2013\n\t\t\t\t\t520."},{"issue":"5","key":"i1551-6776-26-6-541-b47","series-title":"Oncol Rep","first-page":"2455","article-title":"Gene fusions AHRR-NCOA2, NCOA2-ETV4, ETV4-AHRR, P4HA2-TBCK, and TBCK-P4HA2 resulting from the translocations t(5;8;17)(p15;q13;q21) and t(4;5)(q24;q31) in a soft tissue angiofibroma","volume":"36","year":"2016","unstructured":"Panagopoulos\n              I,\n            \n            \n              Gorunova\n              L,\n            \n            \n              Viset\n              T,\n            \n            \n              Heim\n              S.\n            \n          \n          Gene fusions AHRR-NCOA2, NCOA2-ETV4, ETV4-AHRR, P4HA2-TBCK, and TBCK-P4HA2 resulting from the translocations t(5;8;17)(p15;q13;q21) and t(4;5)(q24;q31) in a soft tissue angiofibroma.\n\t\t\t\t\tOncol Rep.\n\t\t\t\t\t2016;\n\t\t\t\t\t36(\n\t\t\t\t\t5):\n\t\t\t\t\t2455\u2013\n\t\t\t\t\t2462."},{"issue":"12","key":"i1551-6776-26-6-541-b48","series-title":"Genes Chromosomes Cancer","first-page":"991","article-title":"Identification of an MLL4-GPS2 fusion as an oncogenic driver of undifferentiated spindle cell sarcoma in a child","volume":"53","year":"2014","unstructured":"O'Meara\n              E,\n            \n            \n              Stack\n              D,\n            \n            \n              Phelan\n              S,\n            \n          \n          .\n\t\t\t\t\tIdentification of an MLL4-GPS2 fusion as an oncogenic driver of undifferentiated spindle cell sarcoma in a child.\n\t\t\t\t\tGenes Chromosomes Cancer.\n\t\t\t\t\t2014;\n\t\t\t\t\t53(\n\t\t\t\t\t12):\n\t\t\t\t\t991\u2013\n\t\t\t\t\t998."},{"key":"i1551-6776-26-6-541-b49","series-title":"Sarcoma","article-title":"Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy","volume":"2012","year":"2012","unstructured":"Przybyl\n              J,\n            \n            \n              Jurkowska\n              M,\n            \n            \n              Rutkowski\n              P,\n            \n          \n          .\n\t\t\t\t\tDownstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy.\n\t\t\t\t\tSarcoma.\n\t\t\t\t\t2012;\n\t\t\t\t\t2012:\n\t\t\t\t\t249219. doi: 10.1155\/2012\/249219"},{"issue":"6","key":"i1551-6776-26-6-541-b50","series-title":"Cancer Cell","first-page":"1128","article-title":"The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma","volume":"33","year":"2018","unstructured":"McBride\n              MJ,\n            \n            \n              Pulice\n              JL,\n            \n            \n              Beird\n              HC,\n            \n          \n          .\n\t\t\t\t\tThe SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma.\n\t\t\t\t\tCancer Cell.\n\t\t\t\t\t2018;\n\t\t\t\t\t33(\n\t\t\t\t\t6):\n\t\t\t\t\t1128\u2013\n\t\t\t\t\t1141e1127."},{"issue":"3","key":"i1551-6776-26-6-541-b51","series-title":"Cancer Cell","first-page":"333","article-title":"Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics","volume":"21","year":"2012","unstructured":"Su\n              L,\n            \n            \n              Sampaio\n              AV,\n            \n            \n              Jones\n              KB,\n            \n          \n          .\n\t\t\t\t\tDeconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics.\n\t\t\t\t\tCancer Cell.\n\t\t\t\t\t2012;\n\t\t\t\t\t21(\n\t\t\t\t\t3):\n\t\t\t\t\t333\u2013\n\t\t\t\t\t347."},{"issue":"4","key":"i1551-6776-26-6-541-b52","series-title":"Biochem Biophys Res Commun","first-page":"713","article-title":"Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells","volume":"432","year":"2013","unstructured":"Hayakawa\n              K,\n            \n            \n              Ikeya\n              M,\n            \n            \n              Fukuta\n              M,\n            \n          \n          .\n\t\t\t\t\tIdentification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells.\n\t\t\t\t\tBiochem Biophys Res Commun.\n\t\t\t\t\t2013;\n\t\t\t\t\t432(\n\t\t\t\t\t4):\n\t\t\t\t\t713\u2013\n\t\t\t\t\t719."},{"issue":"7","key":"i1551-6776-26-6-541-b53","series-title":"Am J Surg Pathol","first-page":"941","article-title":"Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases","volume":"41","year":"2017","unstructured":"Antonescu\n              CR,\n            \n            \n              Owosho\n              AA,\n            \n            \n              Zhang\n              L,\n            \n          \n          .\n\t\t\t\t\tSarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2017;\n\t\t\t\t\t41(\n\t\t\t\t\t7):\n\t\t\t\t\t941\u2013\n\t\t\t\t\t949."},{"key":"i1551-6776-26-6-541-b54","series-title":"Am Soc Clin Oncol Educ Book","first-page":"725","article-title":"Advances in the treatment of pediatric bone sarcomas","volume":"37","year":"2017","unstructured":"Grohar\n              PJ,\n            \n            \n              Janeway\n              KA,\n            \n            \n              Mase\n              LD,\n            \n            \n              Schiffman\n              JD.\n            \n          \n          Advances in the treatment of pediatric bone sarcomas.\n\t\t\t\t\tAm Soc Clin Oncol Educ Book.\n\t\t\t\t\t2017;\n\t\t\t\t\t37:\n\t\t\t\t\t725\u2013\n\t\t\t\t\t735."},{"issue":"33","key":"i1551-6776-26-6-541-b55","series-title":"J Clin Oncol","first-page":"4148","article-title":"Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group","volume":"30","year":"2012","unstructured":"Womer\n              RB,\n            \n            \n              West\n              DC,\n            \n            \n              Krailo\n              MD,\n            \n          \n          .\n\t\t\t\t\tRandomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.\n\t\t\t\t\tJ Clin Oncol.\n\t\t\t\t\t2012;\n\t\t\t\t\t30(\n\t\t\t\t\t33):\n\t\t\t\t\t4148\u2013\n\t\t\t\t\t4154."},{"issue":"31","key":"i1551-6776-26-6-541-b56","series-title":"Proc Natl Acad Sci U S A","first-page":"12944","article-title":"Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia","volume":"106","year":"2009","unstructured":"Radtke\n              I,\n            \n            \n              Mullighan\n              CG,\n            \n            \n              Ishii\n              M,\n            \n          \n          .\n\t\t\t\t\tGenomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia.\n\t\t\t\t\tProc Natl Acad Sci U S A.\n\t\t\t\t\t2009;\n\t\t\t\t\t106(\n\t\t\t\t\t31):\n\t\t\t\t\t12944\u2013\n\t\t\t\t\t12949."},{"issue":"6","key":"i1551-6776-26-6-541-b57","series-title":"Cancer Genet","first-page":"227","article-title":"Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations","volume":"206","year":"2013","unstructured":"Carranza\n              C,\n            \n            \n              Granados\n              L,\n            \n            \n              Morales\n              O,\n            \n          \n          .\n\t\t\t\t\tFrequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations.\n\t\t\t\t\tCancer Genet.\n\t\t\t\t\t2013;\n\t\t\t\t\t206(\n\t\t\t\t\t6):\n\t\t\t\t\t227\u2013\n\t\t\t\t\t232."},{"issue":"11","key":"i1551-6776-26-6-541-b58","series-title":"Blood","first-page":"1265","article-title":"Mixed-phenotype acute leukemia with t(4;11)(q21;q23) KMT2A-AFF1-rearranged","volume":"133","year":"2019","unstructured":"Liu\n              H.\n            \n          \n          Mixed-phenotype acute leukemia with t(4;11)(q21;q23) KMT2A-AFF1-rearranged.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2019;\n\t\t\t\t\t133(\n\t\t\t\t\t11):\n\t\t\t\t\t1265.\n\t\t\t\t\tdoi: 10.1182\/blood-2018-12-893016"},{"issue":"5","key":"i1551-6776-26-6-541-b59","series-title":"Curr Genomics","first-page":"378","article-title":"Recurrent fusion genes in leukemia: an attractive target for diagnosis and treatment","volume":"18","year":"2017","unstructured":"Wang\n              Y,\n            \n            \n              Wu\n              N,\n            \n            \n              Liu\n              D,\n            \n            \n              Jin\n              Y.\n            \n          \n          Recurrent fusion genes in leukemia: an attractive target for diagnosis and treatment.\n\t\t\t\t\tCurr Genomics.\n\t\t\t\t\t2017;\n\t\t\t\t\t18(\n\t\t\t\t\t5):\n\t\t\t\t\t378\u2013\n\t\t\t\t\t384."},{"issue":"1","key":"i1551-6776-26-6-541-b60","series-title":"Pediatr Int","first-page":"41","article-title":"Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia","volume":"60","year":"2018","unstructured":"Matsuo\n              H,\n            \n            \n              Iijima-Yamashita\n              Y,\n            \n            \n              Yamada\n              M,\n            \n          \n          .\n\t\t\t\t\tMonitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia.\n\t\t\t\t\tPediatr Int.\n\t\t\t\t\t2018;\n\t\t\t\t\t60(\n\t\t\t\t\t1):\n\t\t\t\t\t41\u2013\n\t\t\t\t\t46."},{"issue":"6","key":"i1551-6776-26-6-541-b61","series-title":"Iran J Pediatr","first-page":"681","article-title":"Prevalence of ETV6\/RUNX1 fusion gene in pediatric patients with acute lymphoblastic leukemia in Iran","volume":"23","year":"2013","unstructured":"Rahnemoon\n              AR,\n            \n            \n              Zaker\n              F,\n            \n            \n              Izadyar\n              M,\n            \n          \n          .\n\t\t\t\t\tPrevalence of ETV6\/RUNX1 fusion gene in pediatric patients with acute lymphoblastic leukemia in Iran.\n\t\t\t\t\tIran J Pediatr.\n\t\t\t\t\t2013;\n\t\t\t\t\t23(\n\t\t\t\t\t6):\n\t\t\t\t\t681\u2013\n\t\t\t\t\t686."},{"issue":"19","key":"i1551-6776-26-6-541-b62","series-title":"Cancer","first-page":"3807","article-title":"Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues","volume":"123","year":"2017","unstructured":"Majzner\n              RG,\n            \n            \n              Simon\n              JS,\n            \n            \n              Grosso\n              JF,\n            \n          \n          .\n\t\t\t\t\tAssessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues.\n\t\t\t\t\tCancer.\n\t\t\t\t\t2017;\n\t\t\t\t\t123(\n\t\t\t\t\t19):\n\t\t\t\t\t3807\u2013\n\t\t\t\t\t3815."},{"issue":"5","key":"i1551-6776-26-6-541-b63","series-title":"Int J Hematol","first-page":"714","article-title":"Functional analysis of a novel fusion protein PAX5-KIDINS220 identified in a pediatric Ph-like ALL patient","volume":"112","year":"2020","unstructured":"Kanayama\n              T,\n            \n            \n              Imamura\n              T,\n            \n            \n              Mayumi\n              A,\n            \n          \n          .\n\t\t\t\t\tFunctional analysis of a novel fusion protein PAX5-KIDINS220 identified in a pediatric Ph-like ALL patient.\n\t\t\t\t\tInt J Hematol.\n\t\t\t\t\t2020;\n\t\t\t\t\t112(\n\t\t\t\t\t5):\n\t\t\t\t\t714\u2013\n\t\t\t\t\t719."},{"issue":"11","key":"i1551-6776-26-6-541-b64","series-title":"Leukemia","first-page":"2165","article-title":"The MLL recombinome of acute leukemias in 2013","volume":"27","year":"2013","unstructured":"Meyer\n              C,\n            \n            \n              Hofmann\n              J,\n            \n            \n              Burmeister\n              T,\n            \n          \n          .\n\t\t\t\t\tThe MLL recombinome of acute leukemias in 2013.\n\t\t\t\t\tLeukemia.\n\t\t\t\t\t2013;\n\t\t\t\t\t27(\n\t\t\t\t\t11):\n\t\t\t\t\t2165\u2013\n\t\t\t\t\t2176."},{"key":"i1551-6776-26-6-541-b65","series-title":"Front Pediatr","first-page":"4","article-title":"MLL-rearranged leukemias: an update on science and clinical approaches","volume":"5","year":"2017","unstructured":"Winters\n              AC,\n            \n            \n              Bernt\n              KM.\n            \n          \n          MLL-rearranged leukemias: an update on science and clinical approaches.\n\t\t\t\t\tFront Pediatr.\n\t\t\t\t\t2017;\n\t\t\t\t\t5:\n\t\t\t\t\t4.\n\t\t\t\t\tdoi: 10.3389\/fped.2017.00004"},{"issue":"2","key":"i1551-6776-26-6-541-b66","series-title":"Br J Haematol","first-page":"153","article-title":"Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia","volume":"143","year":"2008","unstructured":"Van Vlierberghe\n              P,\n            \n            \n              Pieters\n              R,\n            \n            \n              Beverloo\n              HB,\n            \n            \n              Meijerink\n              JP.\n            \n          \n          Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia.\n\t\t\t\t\tBr J Haematol.\n\t\t\t\t\t2008;\n\t\t\t\t\t143(\n\t\t\t\t\t2):\n\t\t\t\t\t153\u2013\n\t\t\t\t\t168."},{"issue":"4","key":"i1551-6776-26-6-541-b67","series-title":"Blood","first-page":"1264","article-title":"A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia","volume":"98","year":"2001","unstructured":"Jaju\n              RJ,\n            \n            \n              Fidler\n              C,\n            \n            \n              Haas\n              OA,\n            \n          \n          .\n\t\t\t\t\tA novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2001;\n\t\t\t\t\t98(\n\t\t\t\t\t4):\n\t\t\t\t\t1264\u2013\n\t\t\t\t\t1267."},{"issue":"7","key":"i1551-6776-26-6-541-b68","series-title":"Genes Chromosomes Cancer","first-page":"683","article-title":"NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia","volume":"52","year":"2013","unstructured":"Shiba\n              N,\n            \n            \n              Ichikawa\n              H,\n            \n            \n              Taki\n              T,\n            \n          \n          .\n\t\t\t\t\tNUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia.\n\t\t\t\t\tGenes Chromosomes Cancer.\n\t\t\t\t\t2013;\n\t\t\t\t\t52(\n\t\t\t\t\t7):\n\t\t\t\t\t683\u2013\n\t\t\t\t\t693."},{"issue":"7","key":"i1551-6776-26-6-541-b69","series-title":"Leukemia","first-page":"1586","article-title":"Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3)","volume":"30","year":"2016","unstructured":"Bhatnagar\n              B,\n            \n            \n              Blachly\n              JS,\n            \n            \n              Kohlschmidt\n              J,\n            \n          \n          .\n\t\t\t\t\tClinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3).\n\t\t\t\t\tLeukemia.\n\t\t\t\t\t2016;\n\t\t\t\t\t30(\n\t\t\t\t\t7):\n\t\t\t\t\t1586\u2013\n\t\t\t\t\t1589."},{"issue":"11","key":"i1551-6776-26-6-541-b70","series-title":"Biophys J","first-page":"2377","article-title":"Chap-eronin TRiC\/CCT recognizes fusion oncoprotein AML1-ETO through subunit-specific interactions","volume":"110","year":"2016","unstructured":"Roh\n              SH,\n            \n            \n              Kasembeli\n              MM,\n            \n            \n              Galaz-Montoya\n              JG,\n            \n          \n          .\n\t\t\t\t\tChap-eronin TRiC\/CCT recognizes fusion oncoprotein AML1-ETO through subunit-specific interactions.\n\t\t\t\t\tBiophys J.\n\t\t\t\t\t2016;\n\t\t\t\t\t110(\n\t\t\t\t\t11):\n\t\t\t\t\t2377\u2013\n\t\t\t\t\t2385."},{"issue":"4","key":"i1551-6776-26-6-541-b71","series-title":"Leukemia","first-page":"678","article-title":"The role of CALM-AF10 gene fusion in acute leukemia","volume":"22","year":"2008","unstructured":"Caudell\n              D,\n            \n            \n              Aplan\n              PD.\n            \n          \n          The role of CALM-AF10 gene fusion in acute leukemia.\n\t\t\t\t\tLeukemia.\n\t\t\t\t\t2008;\n\t\t\t\t\t22(\n\t\t\t\t\t4):\n\t\t\t\t\t678\u2013\n\t\t\t\t\t685."},{"issue":"9","key":"i1551-6776-26-6-541-b72","series-title":"J Biol Chem","first-page":"4732","article-title":"Chap-eronin TRiC\/CCT modulates the folding and activity of leukemogenic fusion oncoprotein AML1-ETO","volume":"291","year":"2016","unstructured":"Roh\n              SH,\n            \n            \n              Kasembeli\n              M,\n            \n            \n              Galaz-Montoya\n              JG,\n            \n          \n          .\n\t\t\t\t\tChap-eronin TRiC\/CCT modulates the folding and activity of leukemogenic fusion oncoprotein AML1-ETO.\n\t\t\t\t\tJ Biol Chem.\n\t\t\t\t\t2016;\n\t\t\t\t\t291(\n\t\t\t\t\t9):\n\t\t\t\t\t4732\u2013\n\t\t\t\t\t4741."},{"issue":"12","key":"i1551-6776-26-6-541-b73","series-title":"Blood","first-page":"5085","article-title":"Rapid identification of CBFB-MYH11-positive acute myeloid leukemia (AML) cases by one single MYH11 real-time RT-PCR","volume":"101","year":"2003","unstructured":"van der Reijden\n              BA,\n            \n            \n              Massop\n              M,\n            \n            \n              Tonnissen\n              E,\n            \n          \n          .\n\t\t\t\t\tRapid identification of CBFB-MYH11-positive acute myeloid leukemia (AML) cases by one single MYH11 real-time RT-PCR.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2003;\n\t\t\t\t\t101(\n\t\t\t\t\t12):\n\t\t\t\t\t5085\u2013\n\t\t\t\t\t5086."},{"issue":"4","key":"i1551-6776-26-6-541-b74","series-title":"Cancer Genet","first-page":"140","article-title":"A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment","volume":"206","year":"2013","unstructured":"Buijs\n              A,\n            \n            \n              van Wijnen\n              M,\n            \n            \n              van den Blink\n              D,\n            \n          \n          .\n\t\t\t\t\tA ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment.\n\t\t\t\t\tCancer Genet.\n\t\t\t\t\t2013;\n\t\t\t\t\t206(\n\t\t\t\t\t4):\n\t\t\t\t\t140\u2013\n\t\t\t\t\t144."},{"issue":"15","key":"i1551-6776-26-6-541-b75","series-title":"Oncogene","first-page":"1965","article-title":"The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia","volume":"35","year":"2016","unstructured":"Sotoca\n              AM,\n            \n            \n              Prange\n              KH,\n            \n            \n              Reijnders\n              B,\n            \n          \n          .\n\t\t\t\t\tThe oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.\n\t\t\t\t\tOncogene.\n\t\t\t\t\t2016;\n\t\t\t\t\t35(\n\t\t\t\t\t15):\n\t\t\t\t\t1965\u2013\n\t\t\t\t\t1976."},{"issue":"8","key":"i1551-6776-26-6-541-b76","series-title":"Hum Pathol","first-page":"809","article-title":"Detection of NPM\/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia","volume":"34","year":"2003","unstructured":"Arber\n              DA,\n            \n            \n              Chang\n              KL,\n            \n            \n              Lyda\n              MH,\n            \n          \n          .\n\t\t\t\t\tDetection of NPM\/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia.\n\t\t\t\t\tHum Pathol.\n\t\t\t\t\t2003;\n\t\t\t\t\t34(\n\t\t\t\t\t8):\n\t\t\t\t\t809\u2013\n\t\t\t\t\t813."},{"issue":"11","key":"i1551-6776-26-6-541-b77","series-title":"Leukemia","first-page":"1910","article-title":"The t(6;9) associated DEK\/CAN fusion protein targets a population of long-term repopulating hematopoietic stem cells for leukemogenic transformation","volume":"24","year":"2010","unstructured":"Oancea\n              C,\n            \n            \n              Ruster\n              B,\n            \n            \n              Henschler\n              R,\n            \n          \n          .\n\t\t\t\t\tThe t(6;9) associated DEK\/CAN fusion protein targets a population of long-term repopulating hematopoietic stem cells for leukemogenic transformation.\n\t\t\t\t\tLeukemia.\n\t\t\t\t\t2010;\n\t\t\t\t\t24(\n\t\t\t\t\t11):\n\t\t\t\t\t1910\u2013\n\t\t\t\t\t1919."},{"issue":"9","key":"i1551-6776-26-6-541-b78","series-title":"Blood Adv","first-page":"1379","article-title":"Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML","volume":"3","year":"2019","unstructured":"Steinauer\n              N,\n            \n            \n              Guo\n              C,\n            \n            \n              Huang\n              C,\n            \n          \n          .\n\t\t\t\t\tMyeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.\n\t\t\t\t\tBlood Adv.\n\t\t\t\t\t2019;\n\t\t\t\t\t3(\n\t\t\t\t\t9):\n\t\t\t\t\t1379\u2013\n\t\t\t\t\t1393."},{"issue":"8","key":"i1551-6776-26-6-541-b79","series-title":"Blood","first-page":"3451","article-title":"Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)","volume":"109","year":"2007","unstructured":"Akasaka\n              T,\n            \n            \n              Balasas\n              T,\n            \n            \n              Russell\n              LJ,\n            \n          \n          .\n\t\t\t\t\tFive members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).\n\t\t\t\t\tBlood.\n\t\t\t\t\t2007;\n\t\t\t\t\t109(\n\t\t\t\t\t8):\n\t\t\t\t\t3451\u2013\n\t\t\t\t\t3461."},{"issue":"25","key":"i1551-6776-26-6-541-b80","series-title":"J Clin Oncol","first-page":"3100","article-title":"IGH@ translocations, CRLF2 deregulation, and micro-deletions in adolescents and adults with acute lymphoblastic leukemia","volume":"30","year":"2012","unstructured":"Moorman\n              AV,\n            \n            \n              Schwab\n              C,\n            \n            \n              Ensor\n              HM,\n            \n          \n          .\n\t\t\t\t\tIGH@ translocations, CRLF2 deregulation, and micro-deletions in adolescents and adults with acute lymphoblastic leukemia.\n\t\t\t\t\tJ Clin Oncol.\n\t\t\t\t\t2012;\n\t\t\t\t\t30(\n\t\t\t\t\t25):\n\t\t\t\t\t3100\u2013\n\t\t\t\t\t3108."},{"issue":"1","key":"i1551-6776-26-6-541-b81","series-title":"Blood","first-page":"387","article-title":"t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)","volume":"111","year":"2008","unstructured":"Russell\n              LJ,\n            \n            \n              Akasaka\n              T,\n            \n            \n              Majid\n              A,\n            \n          \n          .\n\t\t\t\t\tt(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).\n\t\t\t\t\tBlood.\n\t\t\t\t\t2008;\n\t\t\t\t\t111(\n\t\t\t\t\t1):\n\t\t\t\t\t387\u2013\n\t\t\t\t\t391."},{"issue":"4","key":"i1551-6776-26-6-541-b82","series-title":"Ann Lab Med","first-page":"289","article-title":"MYC rearrangement involving a novel non-immunoglobulin chromosomal locus in precursor B-cell acute lymphoblastic leukemia","volume":"32","year":"2012","unstructured":"Seo\n              JY,\n            \n            \n              Lee\n              SH,\n            \n            \n              Kim\n              HJ,\n            \n          \n          .\n\t\t\t\t\tMYC rearrangement involving a novel non-immunoglobulin chromosomal locus in precursor B-cell acute lymphoblastic leukemia.\n\t\t\t\t\tAnn Lab Med.\n\t\t\t\t\t2012;\n\t\t\t\t\t32(\n\t\t\t\t\t4):\n\t\t\t\t\t289\u2013\n\t\t\t\t\t293."},{"key":"i1551-6776-26-6-541-b83","series-title":"Onco Targets Ther","first-page":"7219","article-title":"E2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol","volume":"9","year":"2016","unstructured":"Hu\n              Y,\n            \n            \n              He\n              H,\n            \n            \n              Lu\n              J,\n            \n          \n          .\n\t\t\t\t\tE2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol.\n\t\t\t\t\tOnco Targets Ther.\n\t\t\t\t\t2016;\n\t\t\t\t\t9:\n\t\t\t\t\t7219\u2013\n\t\t\t\t\t7225."},{"issue":"3","key":"i1551-6776-26-6-541-b84","series-title":"Hematol Rep","first-page":"e15","article-title":"B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy","volume":"4","year":"2012","unstructured":"Carulli\n              G,\n            \n            \n              Marini\n              A,\n            \n            \n              Ferreri\n              MI,\n            \n          \n          .\n\t\t\t\t\tB-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy.\n\t\t\t\t\tHematol Rep.\n\t\t\t\t\t2012;\n\t\t\t\t\t4(\n\t\t\t\t\t3):\n\t\t\t\t\te15.\n\t\t\t\t\tdoi: 10.4081\/hr.2012.e15"},{"issue":"6","key":"i1551-6776-26-6-541-b85","series-title":"Leukemia","first-page":"1121","article-title":"PAX5\/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13)","volume":"17","year":"2003","unstructured":"Strehl\n              S,\n            \n            \n              Konig\n              M,\n            \n            \n              Dworzak\n              MN,\n            \n          \n          .\n\t\t\t\t\tPAX5\/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13).\n\t\t\t\t\tLeukemia.\n\t\t\t\t\t2003;\n\t\t\t\t\t17(\n\t\t\t\t\t6):\n\t\t\t\t\t1121\u2013\n\t\t\t\t\t1123."},{"issue":"6","key":"i1551-6776-26-6-541-b86","series-title":"Ann Hematol","first-page":"863","article-title":"Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course","volume":"91","year":"2012","unstructured":"Put\n              N,\n            \n            \n              Van Roosbroeck\n              K,\n            \n            \n              Konings\n              P,\n            \n          \n          .\n\t\t\t\t\tChronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course.\n\t\t\t\t\tAnn Hematol.\n\t\t\t\t\t2012;\n\t\t\t\t\t91(\n\t\t\t\t\t6):\n\t\t\t\t\t863\u2013\n\t\t\t\t\t873."},{"issue":"2","key":"i1551-6776-26-6-541-b87","series-title":"Blood","first-page":"259","article-title":"Translocation t(2;11) in CLL cells results in CXCR4\/MAML2 fusion onco-gene","volume":"124","year":"2014","unstructured":"Acunzo\n              M,\n            \n            \n              Romano\n              G,\n            \n            \n              Wernicke\n              D,\n            \n          \n          .\n\t\t\t\t\tTranslocation t(2;11) in CLL cells results in CXCR4\/MAML2 fusion onco-gene.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2014;\n\t\t\t\t\t124(\n\t\t\t\t\t2):\n\t\t\t\t\t259\u2013\n\t\t\t\t\t262."},{"key":"i1551-6776-26-6-541-b88","article-title":"Gleevac approval letter","unstructured":"FDA.\n          \n          Gleevac approval letter.\n\t\t\t\t\tUpdated May 10, 2001. Accessed September 10, 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2001\/21335ltr.pdf"},{"issue":"13","key":"i1551-6776-26-6-541-b89","series-title":"FEBS Lett","first-page":"1437","article-title":"Enhanced expression and phosphorylation of the MET oncoprotein by glioma-specific PTPRZ1-MET fusions","volume":"589","year":"2015","unstructured":"Chen\n              HM,\n            \n            \n              Yu\n              K,\n            \n            \n              Tang\n              XY,\n            \n          \n          .\n\t\t\t\t\tEnhanced expression and phosphorylation of the MET oncoprotein by glioma-specific PTPRZ1-MET fusions.\n\t\t\t\t\tFEBS Lett.\n\t\t\t\t\t2015;\n\t\t\t\t\t589(\n\t\t\t\t\t13):\n\t\t\t\t\t1437\u2013\n\t\t\t\t\t1443."},{"issue":"5","key":"i1551-6776-26-6-541-b90","series-title":"Nat Rev Cancer","first-page":"255","article-title":"Targeting chromatin complexes in fusion protein-driven malignancies","volume":"19","year":"2019","unstructured":"Brien\n              GL,\n            \n            \n              Stegmaier\n              K,\n            \n            \n              Armstrong\n              SA.\n            \n          \n          Targeting chromatin complexes in fusion protein-driven malignancies.\n\t\t\t\t\tNat Rev Cancer.\n\t\t\t\t\t2019;\n\t\t\t\t\t19(\n\t\t\t\t\t5):\n\t\t\t\t\t255\u2013\n\t\t\t\t\t269."},{"issue":"suppl 8","key":"i1551-6776-26-6-541-b91","series-title":"Ann Oncol","first-page":"viii23","article-title":"TRK inhibitors in TRK fusion-positive cancers","volume":"30","year":"2019","unstructured":"Drilon\n              A.\n            \n          \n          TRK inhibitors in TRK fusion-positive cancers.\n\t\t\t\t\tAnn Oncol.\n\t\t\t\t\t2019;\n\t\t\t\t\t30(\n\t\t\t\t\tsuppl 8):\n\t\t\t\t\tviii23\u2013\n\t\t\t\t\tviii30."},{"issue":"4","key":"i1551-6776-26-6-541-b92","series-title":"Lancet Oncol","first-page":"531","article-title":"Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials","volume":"21","year":"2020","unstructured":"Hong\n              DS,\n            \n            \n              DuBois\n              SG,\n            \n            \n              Kummar\n              S,\n            \n          \n          .\n\t\t\t\t\tLarotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials.\n\t\t\t\t\tLancet Oncol.\n\t\t\t\t\t2020;\n\t\t\t\t\t21(\n\t\t\t\t\t4):\n\t\t\t\t\t531\u2013\n\t\t\t\t\t540."},{"key":"i1551-6776-26-6-541-b93","series-title":"Front Oncol","first-page":"1458","article-title":"Current and future treatment strategies for rhabdomyosarcoma","volume":"9","year":"2019","unstructured":"Chen\n              C,\n            \n            \n              Dorado Garcia\n              H,\n            \n            \n              Scheer\n              M,\n            \n            \n              Henssen\n              AG.\n            \n          \n          Current and future treatment strategies for rhabdomyosarcoma.\n\t\t\t\t\tFront Oncol.\n\t\t\t\t\t2019;\n\t\t\t\t\t9:\n\t\t\t\t\t1458.\n\t\t\t\t\tdoi: 10.3389\/fonc.2019.01458"},{"issue":"2","key":"i1551-6776-26-6-541-b94","series-title":"N Engl J Med","first-page":"111","article-title":"Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","year":"2013","unstructured":"Lo-Coco\n              F,\n            \n            \n              Avvisati\n              G,\n            \n            \n              Vignetti\n              M,\n            \n          \n          .\n\t\t\t\t\tRetinoic acid and arsenic trioxide for acute promyelocytic leukemia.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2013;\n\t\t\t\t\t369(\n\t\t\t\t\t2):\n\t\t\t\t\t111\u2013\n\t\t\t\t\t121."},{"issue":"20","key":"i1551-6776-26-6-541-b95","series-title":"Clin Cancer Res","first-page":"4733","article-title":"Clinical application of prognostic gene expression signature in fusion gene-negative rhabdomyosarcoma: a report from the Children's Oncology Group","volume":"21","year":"2015","unstructured":"Hingorani\n              P,\n            \n            \n              Missiaglia\n              E,\n            \n            \n              Shipley\n              J,\n            \n          \n          .\n\t\t\t\t\tClinical application of prognostic gene expression signature in fusion gene-negative rhabdomyosarcoma: a report from the Children's Oncology Group.\n\t\t\t\t\tClin Cancer Res.\n\t\t\t\t\t2015;\n\t\t\t\t\t21(\n\t\t\t\t\t20):\n\t\t\t\t\t4733\u2013\n\t\t\t\t\t4739."},{"issue":"40","key":"i1551-6776-26-6-541-b96","series-title":"Oncotarget","first-page":"65540","article-title":"STA-8666, a novel HSP90 inhibitor\/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcoma","volume":"7","year":"2016","unstructured":"Heske\n              CM,\n            \n            \n              Mendoza\n              A,\n            \n            \n              Edessa\n              LD,\n            \n          \n          .\n\t\t\t\t\tSTA-8666, a novel HSP90 inhibitor\/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcoma.\n\t\t\t\t\tOncotarget.\n\t\t\t\t\t2016;\n\t\t\t\t\t7(\n\t\t\t\t\t40):\n\t\t\t\t\t65540\u2013\n\t\t\t\t\t65552."},{"issue":"18","key":"i1551-6776-26-6-541-b97","series-title":"Cancer","first-page":"4218","article-title":"Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005","volume":"115","year":"2009","unstructured":"Ognjanovic\n              S,\n            \n            \n              Linabery\n              AM,\n            \n            \n              Charbonneau\n              B,\n            \n            \n              Ross\n              JA.\n            \n          \n          Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005.\n\t\t\t\t\tCancer.\n\t\t\t\t\t2009;\n\t\t\t\t\t115(\n\t\t\t\t\t18):\n\t\t\t\t\t4218\u2013\n\t\t\t\t\t4226."},{"issue":"2","key":"i1551-6776-26-6-541-b98","series-title":"Cancer Discov","first-page":"216","article-title":"Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors","volume":"4","year":"2014","unstructured":"Shern\n              JF,\n            \n            \n              Chen\n              L,\n            \n            \n              Chmielecki\n              J,\n            \n          \n          .\n\t\t\t\t\tComprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.\n\t\t\t\t\tCancer Discov.\n\t\t\t\t\t2014;\n\t\t\t\t\t4(\n\t\t\t\t\t2):\n\t\t\t\t\t216\u2013\n\t\t\t\t\t231."},{"issue":"1","key":"i1551-6776-26-6-541-b99","series-title":"PLoS Genet","first-page":"e1004107","article-title":"Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcoma","volume":"10","year":"2014","unstructured":"Kikuchi\n              K,\n            \n            \n              Hettmer\n              S,\n            \n            \n              Aslam\n              MI,\n            \n          \n          .\n\t\t\t\t\tCell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcoma.\n\t\t\t\t\tPLoS Genet.\n\t\t\t\t\t2014;\n\t\t\t\t\t10(\n\t\t\t\t\t1):\n\t\t\t\t\te1004107.\n\t\t\t\t\tdoi: 10.1371\/journal.pgen.1004107"},{"issue":"9","key":"i1551-6776-26-6-541-b100","series-title":"Cancer","first-page":"1973","article-title":"Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: a report from the Children's Oncology Group","volume":"124","year":"2018","unstructured":"Teot\n              LA,\n            \n            \n              Schneider\n              M,\n            \n            \n              Thorner\n              AR,\n            \n          \n          .\n\t\t\t\t\tClinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: a report from the Children's Oncology Group.\n\t\t\t\t\tCancer.\n\t\t\t\t\t2018;\n\t\t\t\t\t124(\n\t\t\t\t\t9):\n\t\t\t\t\t1973\u2013\n\t\t\t\t\t1981."},{"issue":"557","key":"i1551-6776-26-6-541-b101","series-title":"Sci Signal","first-page":"eaau7632","article-title":"The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma","volume":"11","year":"2018","unstructured":"Bharathy\n              N,\n            \n            \n              Berlow\n              NE,\n            \n            \n              Wang\n              E,\n            \n          \n          .\n\t\t\t\t\tThe HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma.\n\t\t\t\t\tSci Signal.\n\t\t\t\t\t2018;\n\t\t\t\t\t11(\n\t\t\t\t\t557):\n\t\t\t\t\teaau7632.\n\t\t\t\t\tdoi: 10.1126\/scisignal.aau7632"},{"issue":"11","key":"i1551-6776-26-6-541-b102","series-title":"Stem Cells","first-page":"2304","article-title":"IL-4 receptor blockade abrogates satellite cell: rhabdomyosarcoma fusion and prevents tumor establishment","volume":"31","year":"2013","unstructured":"Li\n              G,\n            \n            \n              Kikuchi\n              K,\n            \n            \n              Radka\n              M,\n            \n          \n          .\n\t\t\t\t\tIL-4 receptor blockade abrogates satellite cell: rhabdomyosarcoma fusion and prevents tumor establishment.\n\t\t\t\t\tStem Cells.\n\t\t\t\t\t2013;\n\t\t\t\t\t31(\n\t\t\t\t\t11):\n\t\t\t\t\t2304\u2013\n\t\t\t\t\t2312."},{"issue":"7","key":"i1551-6776-26-6-541-b103","series-title":"Nat Rev Clin Oncol","first-page":"356","article-title":"Pediatric oncology: Fusion-gene status crucial in RMS","volume":"7","year":"2010","unstructured":"Kirk\n              R.\n            \n          \n          Pediatric oncology: Fusion-gene status crucial in RMS.\n\t\t\t\t\tNat Rev Clin Oncol.\n\t\t\t\t\t2010;\n\t\t\t\t\t7(\n\t\t\t\t\t7):\n\t\t\t\t\t356.\n\t\t\t\t\tdoi: 10.1038\/nrclinonc.2010.88"},{"issue":"13","key":"i1551-6776-26-6-541-b104","series-title":"J Clin Oncol","first-page":"2151","article-title":"Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma","volume":"28","year":"2010","unstructured":"Williamson\n              D,\n            \n            \n              Missiaglia\n              E,\n            \n            \n              de Reynies\n              A,\n            \n          \n          .\n\t\t\t\t\tFusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.\n\t\t\t\t\tJ Clin Oncol.\n\t\t\t\t\t2010;\n\t\t\t\t\t28(\n\t\t\t\t\t13):\n\t\t\t\t\t2151\u2013\n\t\t\t\t\t2158."},{"issue":"1","key":"i1551-6776-26-6-541-b105","series-title":"Cancer Genet Cytogenet","first-page":"1","article-title":"Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC-DUX4 fusion gene event","volume":"195","year":"2009","unstructured":"Yoshimoto\n              M,\n            \n            \n              Graham\n              C,\n            \n            \n              Chilton-MacNeill\n              S,\n            \n          \n          .\n\t\t\t\t\tDetailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC-DUX4 fusion gene event.\n\t\t\t\t\tCancer Genet Cytogenet.\n\t\t\t\t\t2009;\n\t\t\t\t\t195(\n\t\t\t\t\t1):\n\t\t\t\t\t1\u2013\n\t\t\t\t\t11."},{"key":"i1551-6776-26-6-541-b106","series-title":"Curr Top Dev Biol","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-12-385940-2.00002-4","article-title":"Developmental origins of fusion-negative rhabdomyosarcomas","volume":"96","year":"2011","unstructured":"Kikuchi\n              K,\n            \n            \n              Rubin\n              BP,\n            \n            \n              Keller\n              C.\n            \n          \n          Developmental origins of fusion-negative rhabdomyosarcomas.\n\t\t\t\t\tCurr Top Dev Biol.\n\t\t\t\t\t2011;\n\t\t\t\t\t96:\n\t\t\t\t\t33\u2013\n\t\t\t\t\t56."},{"issue":"5","key":"i1551-6776-26-6-541-b107","series-title":"Clin Cancer Res","first-page":"1135","article-title":"Genomic determinants of clinical outcomes in rhabdomyosarcoma","volume":"26","year":"2020","unstructured":"Casey\n              DL,\n            \n            \n              Wexler\n              LH,\n            \n            \n              Pitter\n              KL,\n            \n          \n          .\n\t\t\t\t\tGenomic determinants of clinical outcomes in rhabdomyosarcoma.\n\t\t\t\t\tClin Cancer Res.\n\t\t\t\t\t2020;\n\t\t\t\t\t26(\n\t\t\t\t\t5):\n\t\t\t\t\t1135\u2013\n\t\t\t\t\t1140."},{"issue":"8","key":"i1551-6776-26-6-541-b108","series-title":"Cancer Res","first-page":"2000","article-title":"NRAS-mutated rhabdomyosarcoma cells are vulnerable to mitochondrial apoptosis induced by coinhibition of MEK and PI3Kalpha","volume":"78","year":"2018","unstructured":"Dolgikh\n              N,\n            \n            \n              Hugle\n              M,\n            \n            \n              Vogler\n              M,\n            \n            \n              Fulda\n              S.\n            \n          \n          NRAS-mutated rhabdomyosarcoma cells are vulnerable to mitochondrial apoptosis induced by coinhibition of MEK and PI3Kalpha.\n\t\t\t\t\tCancer Res.\n\t\t\t\t\t2018;\n\t\t\t\t\t78(\n\t\t\t\t\t8):\n\t\t\t\t\t2000\u2013\n\t\t\t\t\t2013."},{"issue":"29","key":"i1551-6776-26-6-541-b109","series-title":"Oncotarget","first-page":"46283","article-title":"RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-kappaB pathway, independently of the fusion oncoprotein","volume":"7","year":"2016","unstructured":"Hernandez-Munoz\n              I,\n            \n            \n              Figuerola\n              E,\n            \n            \n              Sanchez-Molina\n              S,\n            \n          \n          .\n\t\t\t\t\tRING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-kappaB pathway, independently of the fusion oncoprotein.\n\t\t\t\t\tOncotarget.\n\t\t\t\t\t2016;\n\t\t\t\t\t7(\n\t\t\t\t\t29):\n\t\t\t\t\t46283\u2013\n\t\t\t\t\t46300."},{"key":"i1551-6776-26-6-541-b110","series-title":"F1000Res","first-page":"5","article-title":"Recent advances in targeted therapy for Ewing sarcoma","year":"2016","unstructured":"Pishas\n              KI,\n            \n            \n              Lessnick\n              SL.\n            \n          \n          Recent advances in targeted therapy for Ewing sarcoma.\n\t\t\t\t\tF1000Res.\n\t\t\t\t\t2016;\n\t\t\t\t\t5.\n\t\t\t\t\tdoi: 10.12688\/f1000research.8631.1"},{"issue":"1","key":"i1551-6776-26-6-541-b111","series-title":"Virchows Arch","first-page":"109","article-title":"Ewing sarcoma and Ewing-like tumors","volume":"476","year":"2020","unstructured":"Sbaraglia\n              M,\n            \n            \n              Righi\n              A,\n            \n            \n              Gambarotti\n              M,\n            \n            \n              Dei Tos\n              AP.\n            \n          \n          Ewing sarcoma and Ewing-like tumors.\n\t\t\t\t\tVirchows Arch.\n\t\t\t\t\t2020;\n\t\t\t\t\t476(\n\t\t\t\t\t1):\n\t\t\t\t\t109\u2013\n\t\t\t\t\t119."},{"key":"i1551-6776-26-6-541-b112","series-title":"Front Oncol","first-page":"1078","article-title":"Epigenetic targets in synovial sarcoma: a mini-review","volume":"9","year":"2019","unstructured":"Hale\n              R,\n            \n            \n              Sandakly\n              S,\n            \n            \n              Shipley\n              J,\n            \n            \n              Walters\n              Z.\n            \n          \n          Epigenetic targets in synovial sarcoma: a mini-review.\n\t\t\t\t\tFront Oncol.\n\t\t\t\t\t2019;\n\t\t\t\t\t9:\n\t\t\t\t\t1078.\n\t\t\t\t\tdoi:XXX"},{"issue":"5","key":"i1551-6776-26-6-541-b113","series-title":"Cell Death Dis","first-page":"446","article-title":"Inhibition of cyclin-dependent kinase 4 as a potential therapeutic strategy for treatment of synovial sarcoma","volume":"9","year":"2018","unstructured":"Li\n              X,\n            \n            \n              Seebacher\n              NA,\n            \n            \n              Garbutt\n              C,\n            \n          \n          .\n\t\t\t\t\tInhibition of cyclin-dependent kinase 4 as a potential therapeutic strategy for treatment of synovial sarcoma.\n\t\t\t\t\tCell Death Dis.\n\t\t\t\t\t2018;\n\t\t\t\t\t9(\n\t\t\t\t\t5):\n\t\t\t\t\t446.\n\t\t\t\t\tdoi: 10.1038\/s41419-018-0474-4"},{"issue":"12","key":"i1551-6776-26-6-541-b114","series-title":"FEBS Lett","first-page":"2662","article-title":"The molecular signature of oncofusion proteins in acute myeloid leukemia","volume":"584","year":"2010","unstructured":"Martens\n              JH,\n            \n            \n              Stunnenberg\n              HG.\n            \n          \n          The molecular signature of oncofusion proteins in acute myeloid leukemia.\n\t\t\t\t\tFEBS Lett.\n\t\t\t\t\t2010;\n\t\t\t\t\t584(\n\t\t\t\t\t12):\n\t\t\t\t\t2662\u2013\n\t\t\t\t\t2669."},{"issue":"1","key":"i1551-6776-26-6-541-b115","series-title":"Pediatr Int","first-page":"47","article-title":"Multiplex fusion gene testing in pediatric acute myeloid leukemia","volume":"60","year":"2018","unstructured":"Iijima-Yamashita\n              Y,\n            \n            \n              Matsuo\n              H,\n            \n            \n              Yamada\n              M,\n            \n          \n          .\n\t\t\t\t\tMultiplex fusion gene testing in pediatric acute myeloid leukemia.\n\t\t\t\t\tPediatr Int.\n\t\t\t\t\t2018;\n\t\t\t\t\t60(\n\t\t\t\t\t1):\n\t\t\t\t\t47\u2013\n\t\t\t\t\t51."},{"issue":"10","key":"i1551-6776-26-6-541-b116","series-title":"Leukemia","first-page":"1570","article-title":"IDH1 and IDH2 mutations in pediatric acute leukemia","volume":"25","year":"2011","unstructured":"Andersson\n              AK,\n            \n            \n              Miller\n              DW,\n            \n            \n              Lynch\n              JA,\n            \n          \n          .\n\t\t\t\t\tIDH1 and IDH2 mutations in pediatric acute leukemia.\n\t\t\t\t\tLeukemia.\n\t\t\t\t\t2011;\n\t\t\t\t\t25(\n\t\t\t\t\t10):\n\t\t\t\t\t1570\u2013\n\t\t\t\t\t1577."},{"issue":"27","key":"i1551-6776-26-6-541-b117","series-title":"Oncogene","first-page":"2502","article-title":"RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress","volume":"28","year":"2009","unstructured":"Wolyniec\n              K,\n            \n            \n              Wotton\n              S,\n            \n            \n              Kilbey\n              A,\n            \n          \n          .\n\t\t\t\t\tRUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress.\n\t\t\t\t\tOncogene.\n\t\t\t\t\t2009;\n\t\t\t\t\t28(\n\t\t\t\t\t27):\n\t\t\t\t\t2502\u2013\n\t\t\t\t\t2512."},{"issue":"11","key":"i1551-6776-26-6-541-b118","series-title":"Cold Spring Harb Perspect Med","first-page":"a026658","article-title":"Mixed-lineage leukemia fusions and chromatin in leukemia","volume":"7","year":"2017","unstructured":"Krivtsov\n              AV,\n            \n            \n              Hoshii\n              T,\n            \n            \n              Armstrong\n              SA.\n            \n          \n          Mixed-lineage leukemia fusions and chromatin in leukemia.\n\t\t\t\t\tCold Spring Harb Perspect Med.\n\t\t\t\t\t2017;\n\t\t\t\t\t7(\n\t\t\t\t\t11):\n\t\t\t\t\ta026658.\n\t\t\t\t\tdoi: 10.1101\/cshperspect.a026658."},{"issue":"6","key":"i1551-6776-26-6-541-b119","series-title":"Exp Hematol","first-page":"481","article-title":"Activation of Ras-dependent Elk-1 activity by MLL-AF4 family fusion oncoproteins","volume":"38","year":"2010","unstructured":"Ng\n              MH,\n            \n            \n              Ng\n              RK,\n            \n            \n              Kong\n              CT,\n            \n          \n          .\n\t\t\t\t\tActivation of Ras-dependent Elk-1 activity by MLL-AF4 family fusion oncoproteins.\n\t\t\t\t\tExp Hematol.\n\t\t\t\t\t2010;\n\t\t\t\t\t38(\n\t\t\t\t\t6):\n\t\t\t\t\t481\u2013\n\t\t\t\t\t488."},{"issue":"13","key":"i1551-6776-26-6-541-b120","series-title":"Blood","first-page":"2533","article-title":"Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l","volume":"121","year":"2013","unstructured":"Deshpande\n              AJ,\n            \n            \n              Chen\n              L,\n            \n            \n              Fazio\n              M,\n            \n          \n          .\n\t\t\t\t\tLeukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2013;\n\t\t\t\t\t121(\n\t\t\t\t\t13):\n\t\t\t\t\t2533\u2013\n\t\t\t\t\t2541."},{"key":"i1551-6776-26-6-541-b121","series-title":"Front Pediatr","first-page":"463","article-title":"Targeted therapies for pediatric AML: gaps and perspective","volume":"7","year":"2019","unstructured":"Lonetti\n              A,\n            \n            \n              Pession\n              A,\n            \n            \n              Masetti\n              R.\n            \n          \n          Targeted therapies for pediatric AML: gaps and perspective.\n\t\t\t\t\tFront Pediatr.\n\t\t\t\t\t2019;\n\t\t\t\t\t7:\n\t\t\t\t\t463.\n\t\t\t\t\tdoi: 10.3389\/fped.2019.00463"},{"issue":"11","key":"i1551-6776-26-6-541-b122","series-title":"Cancers (Basel)","first-page":"1625","article-title":"Clinical challenges and consequences of measurable residual disease in non-APL acute myeloid leukemia","volume":"11","year":"2019","unstructured":"Jentzsch\n              M,\n            \n            \n              Schwind\n              S,\n            \n            \n              Bach\n              E,\n            \n          \n          .\n\t\t\t\t\tClinical challenges and consequences of measurable residual disease in non-APL acute myeloid leukemia.\n\t\t\t\t\tCancers (Basel).\n\t\t\t\t\t2019;\n\t\t\t\t\t11(\n\t\t\t\t\t11):\n\t\t\t\t\t1625.\n\t\t\t\t\tdoi: 10.3390\/cancers11111625"},{"key":"i1551-6776-26-6-541-b123","series-title":"Mol Cytogenet","first-page":"48","article-title":"PAX5-KIAA1549L: a novel fusion gene in a case of pediatric B-cell precursor acute lymphoblastic leukemia","volume":"8","year":"2015","unstructured":"Anderl\n              S,\n            \n            \n              Konig\n              M,\n            \n            \n              Attarbaschi\n              A,\n            \n            \n              Strehl\n              S.\n            \n          \n          PAX5-KIAA1549L: a novel fusion gene in a case of pediatric B-cell precursor acute lymphoblastic leukemia.\n\t\t\t\t\tMol Cytogenet.\n\t\t\t\t\t2015;\n\t\t\t\t\t8:\n\t\t\t\t\t48.\n\t\t\t\t\tdoi: 10.1186\/s13039-015-0138-3"},{"issue":"8","key":"i1551-6776-26-6-541-b124","series-title":"Nat Genet","first-page":"1211","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","year":"2017","unstructured":"Liu\n              Y,\n            \n            \n              Easton\n              J,\n            \n            \n              Shao\n              Y,\n            \n          \n          .\n\t\t\t\t\tThe genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.\n\t\t\t\t\tNat Genet.\n\t\t\t\t\t2017;\n\t\t\t\t\t49(\n\t\t\t\t\t8):\n\t\t\t\t\t1211\u2013\n\t\t\t\t\t1218."},{"issue":"3","key":"i1551-6776-26-6-541-b125","series-title":"Blood","first-page":"485","article-title":"Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project","volume":"121","year":"2013","unstructured":"Loh\n              ML,\n            \n            \n              Zhang\n              J,\n            \n            \n              Harvey\n              RC,\n            \n          \n          .\n\t\t\t\t\tTyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2013;\n\t\t\t\t\t121(\n\t\t\t\t\t3):\n\t\t\t\t\t485\u2013\n\t\t\t\t\t488."},{"issue":"6","key":"i1551-6776-26-6-541-b126","series-title":"Blood","first-page":"1165","article-title":"Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?","volume":"120","year":"2012","unstructured":"Pui\n              CH,\n            \n            \n              Mullighan\n              CG,\n            \n            \n              Evans\n              WE,\n            \n            \n              Relling\n              MV.\n            \n          \n          Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?\n          \n            Blood\n          .\n\t\t\t\t\t2012;\n\t\t\t\t\t120(\n\t\t\t\t\t6):\n\t\t\t\t\t1165\u2013\n\t\t\t\t\t1174."},{"issue":"7","key":"i1551-6776-26-6-541-b127","series-title":"Blood","first-page":"1394","article-title":"Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia","volume":"115","year":"2010","unstructured":"Kang\n              H,\n            \n            \n              Chen\n              IM,\n            \n            \n              Wilson\n              CS,\n            \n          \n          .\n\t\t\t\t\tGene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2010;\n\t\t\t\t\t115(\n\t\t\t\t\t7):\n\t\t\t\t\t1394\u2013\n\t\t\t\t\t1405."},{"issue":"23","key":"i1551-6776-26-6-541-b128","series-title":"Blood","first-page":"4874","article-title":"Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome","volume":"116","year":"2010","unstructured":"Harvey\n              RC,\n            \n            \n              Mullighan\n              CG,\n            \n            \n              Wang\n              X,\n            \n          \n          .\n\t\t\t\t\tIdentification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2010;\n\t\t\t\t\t116(\n\t\t\t\t\t23):\n\t\t\t\t\t4874\u2013\n\t\t\t\t\t4884."},{"issue":"26","key":"i1551-6776-26-6-541-b129","series-title":"Blood","first-page":"5312","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","year":"2010","unstructured":"Harvey\n              RC,\n            \n            \n              Mullighan\n              CG,\n            \n            \n              Chen\n              IM,\n            \n          \n          .\n\t\t\t\t\tRearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2010;\n\t\t\t\t\t115(\n\t\t\t\t\t26):\n\t\t\t\t\t5312\u2013\n\t\t\t\t\t5321."},{"key":"i1551-6776-26-6-541-b130","series-title":"Nat Commun","first-page":"13331","article-title":"Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia","volume":"7","year":"2016","unstructured":"Gu\n              Z,\n            \n            \n              Churchman\n              M,\n            \n            \n              Roberts\n              K,\n            \n          \n          .\n\t\t\t\t\tGenomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.\n\t\t\t\t\tNat Commun.\n\t\t\t\t\t2016;\n\t\t\t\t\t7:\n\t\t\t\t\t13331.\n\t\t\t\t\tdoi: 10.1038\/ncomms13331"},{"issue":"9","key":"i1551-6776-26-6-541-b131","series-title":"Haematologica","first-page":"1082","article-title":"Characterization of leukemias with ETV6-ABL1 fusion","volume":"101","year":"2016","unstructured":"Zaliova\n              M,\n            \n            \n              Moorman\n              AV,\n            \n            \n              Cazzaniga\n              G,\n            \n          \n          .\n\t\t\t\t\tCharacterization of leukemias with ETV6-ABL1 fusion.\n\t\t\t\t\tHaematologica.\n\t\t\t\t\t2016;\n\t\t\t\t\t101(\n\t\t\t\t\t9):\n\t\t\t\t\t1082\u2013\n\t\t\t\t\t1093."},{"issue":"25","key":"i1551-6776-26-6-541-b132","series-title":"Blood","first-page":"3352","article-title":"Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group","volume":"129","year":"2017","unstructured":"Reshmi\n              SC,\n            \n            \n              Harvey\n              RC,\n            \n            \n              Roberts\n              KG,\n            \n          \n          .\n\t\t\t\t\tTargetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2017;\n\t\t\t\t\t129(\n\t\t\t\t\t25):\n\t\t\t\t\t3352\u2013\n\t\t\t\t\t3361."},{"issue":"20","key":"i1551-6776-26-6-541-b133","series-title":"Blood","first-page":"2391","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","year":"2016","unstructured":"Arber\n              DA,\n            \n            \n              Orazi\n              A,\n            \n            \n              Hasserjian\n              R,\n            \n          \n          .\n\t\t\t\t\tThe 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2016;\n\t\t\t\t\t127(\n\t\t\t\t\t20):\n\t\t\t\t\t2391\u2013\n\t\t\t\t\t2405."},{"issue":"20","key":"i1551-6776-26-6-541-b134","series-title":"Blood","first-page":"2391","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","year":"2016","unstructured":"Arber\n              DA,\n            \n            \n              Orazi\n              A,\n            \n            \n              Hasserjian\n              R,\n            \n          \n          .\n\t\t\t\t\tThe 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2016;\n\t\t\t\t\t127(\n\t\t\t\t\t20):\n\t\t\t\t\t2391\u2013\n\t\t\t\t\t2405.\n\t\t\t\t\tBlood. 2016;128(3):462\u2013463."},{"key":"i1551-6776-26-6-541-b135","article-title":"Administrative supplements to promote research collaborations on fusion oncoproteins as drivers of childhood cancer","unstructured":"NIH.\n          \n          Administrative supplements to promote research collaborations on fusion oncoproteins as drivers of childhood cancer.\n\t\t\t\t\tUpdated January 26, 2017. Accessed September 23 2020. https:\/\/grants.nih.gov\/grants\/guide\/pa-files\/PA-17-138.html"},{"key":"i1551-6776-26-6-541-b136","article-title":"Cancer Moonshot Blue Ribbon Panel","unstructured":"NIH.\n          \n          Cancer Moonshot Blue Ribbon Panel.\n\t\t\t\t\tUpdated April 26, 2017. Accessed September 23, 2020. https:\/\/www.cancer.gov\/research\/key-initiatives\/moonshot-cancer-initiative\/blue-ribbon-panel"},{"issue":"5","key":"i1551-6776-26-6-541-b137","series-title":"JAMA Oncol","first-page":"575","article-title":"Precision therapy for pediatric cancers","volume":"2","year":"2016","unstructured":"Khan\n              J,\n            \n            \n              Helman\n              LJ.\n            \n          \n          Precision therapy for pediatric cancers.\n\t\t\t\t\tJAMA Oncol.\n\t\t\t\t\t2016;\n\t\t\t\t\t2(\n\t\t\t\t\t5):\n\t\t\t\t\t575\u2013\n\t\t\t\t\t577."},{"key":"i1551-6776-26-6-541-b138","article-title":"Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium","unstructured":"NIH.\n          \n          Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium.\n\t\t\t\t\tPublished 2020. Updated September 11, 2018. Accessed September 23, 2020. https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-CA-19-016.html"},{"key":"i1551-6776-26-6-541-b139","article-title":"Cancer Moonshot\u2014funding opportunities","unstructured":"NIH.\n          \n          Cancer Moonshot\u2014funding opportunities.\n\t\t\t\t\tUpdated September 10, 2020. Accessed September 24, 2020. https:\/\/www.cancer.gov\/research\/key-initiatives\/moonshot-cancer-initiative\/funding"},{"key":"i1551-6776-26-6-541-b140","article-title":"Gene fusions in pediatric sarcomas (R21)","unstructured":"NIH.\n          \n          Gene fusions in pediatric sarcomas (R21).\n\t\t\t\t\tUpdated May 10, 2016. Accessed September 24, 2020. https:\/\/grants.nih.gov\/grants\/guide\/pa-files\/PA-16-252.html"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/26\/6\/article-p541.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/26\/6\/541\/2886105\/i1551-6776-26-6-541.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/26\/6\/article-p541.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/26\/6\/article-p541.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:46:24Z","timestamp":1747356384000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/26\/6\/article-p541.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":140,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-26.6.541","relation":{},"ISSN":["1551-6776"],"issn-type":[{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}